{
    "id": "dbpedia_8607_0",
    "rank": 13,
    "data": {
        "url": "https://aacrjournals.org/clincancerres/article/30/8/1630/742130/Obinutuzumab-Pretreatment-as-a-Novel-Approach-to",
        "read_more_link": "",
        "language": "en",
        "title": "Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors",
        "top_image": "https://aacrjournals.org/UI/app/svg/umbrella/logo.svg",
        "meta_img": "https://aacrjournals.org/UI/app/svg/umbrella/logo.svg",
        "images": [
            "https://aacr.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/images/umbrella/umbrella-logo.svg",
            "https://aacr.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/images/umbrella/umbrella-logo.svg",
            "https://aacr.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/clincancerres/CCR-title-973029469.svg",
            "https://aacr.silverchair-cdn.com/aacr/content_public/journal/clincancerres/issue/30/8/3/m_clincanres_30_8_cover.png?Expires=1727061321&Signature=g7KLv1oEF4omoxeEdHWDl76WWTiHi6DGwwFWtPZAXSrnkzQ1XipDXe8cP11KTdijLpj7cKMEbqUySeVuj97tVud~6PnQERA~fcFdHm18xUAUGOd2yaH-w6jZP38Nl00Hg2wqZBrRyQnkJEJSk-2pRUwZ1j-k0zLY7f4fHe2PnEjGGbtByYKml4cS8G1GqfRjW8Mr~ENPZDic8Ibza2InuHnUxzQV5np5nRU6OQ5ne7NgsviFdKpOt1hYe6cjARjIpHZbsi1oc40nie1C9f~wtoInwgov-0YfLpLpPFen6A0NW8cSUTXp8AIw8syH~7CbHP6z0LafbnwqePuPz75EXg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://aacr.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png",
            "https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg",
            "https://aacr.silverchair-cdn.com/ImageLibrary/umbrella/icons/RSS-icon-16px.png?versionId=6455",
            "https://aacr.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/images/umbrella/footer-logo.svg?versionId=6455"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Peters, Solange",
            "Angevin, Eric",
            "Alonso-Gordoa, Teresa",
            "Rohrberg, Kristoffer",
            "Melero, Ignacio",
            "Mellado, Begoña",
            "Perez-Gracia, Jose-Luis",
            "Tabernero, Josep",
            "Adessi, Celine",
            "Boetsch, Christophe"
        ],
        "publish_date": "2024-04-15T00:00:00",
        "summary": "",
        "meta_description": "AbstractPurpose:. The immunocytokine cergutuzumab amunaleukin (CEA-IL2v) showed manageable safety and favorable pharmacodynamics in phase I/Ib trials in",
        "meta_lang": "en",
        "meta_favicon": "//aacr.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/Images/umbrella/apple-touch-icon.png",
        "meta_site_name": "American Association for Cancer Research",
        "canonical_link": "https://aacrjournals.org/clincancerres/article/30/8/1630/742130/Obinutuzumab-Pretreatment-as-a-Novel-Approach-to",
        "text": "Solange Peters ;\n\nSolange Peters\n\n1Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne University, Lausanne, Switzerland.\n\n*Corresponding Author: Solange Peters, Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne University, Ch. Des Boveresses 155, Lausanne, CH-1066 Epalinges, Switzerland. E-mail: solange.peters@chuv.ch\n\nSearch for other works by this author on:\n\nEric Angevin ;\n\nEric Angevin\n\n2Drug Development Department (DITEP), Institut Gustave Roussy, Villejuif, France.\n\nSearch for other works by this author on:\n\nTeresa Alonso-Gordoa ;\n\nTeresa Alonso-Gordoa\n\n3Medical Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain.\n\nSearch for other works by this author on:\n\nKristoffer Rohrberg ;\n\nKristoffer Rohrberg\n\n4Phase 1 Unit, Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.\n\nSearch for other works by this author on:\n\nIgnacio Melero ;\n\nIgnacio Melero\n\n5Oncology and Immunology Department, Clinica Universidad de Navarra and CIBERONC, Pamplona, Spain.\n\nSearch for other works by this author on:\n\nBegoña Mellado ;\n\nBegoña Mellado\n\n6Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.\n\n7Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.\n\n8Department of Medicine, University of Barcelona, Barcelona, Spain.\n\nSearch for other works by this author on:\n\nJose-Luis Perez-Gracia ;\n\nJose-Luis Perez-Gracia\n\n5Oncology and Immunology Department, Clinica Universidad de Navarra and CIBERONC, Pamplona, Spain.\n\nSearch for other works by this author on:\n\nJosep Tabernero ;\n\nJosep Tabernero\n\n9Medical Oncology Department, Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), UVic-UCC, IOB-Quiron, Barcelona, Spain.\n\nSearch for other works by this author on:\n\nCeline Adessi ;\n\nCeline Adessi\n\n10F. Hoffmann-La Roche Ltd, Research & Early Development Oncology, Basel, Switzerland.\n\nSearch for other works by this author on:\n\nChristophe Boetsch ;\n\nChristophe Boetsch\n\n10F. Hoffmann-La Roche Ltd, Research & Early Development Oncology, Basel, Switzerland.\n\nSearch for other works by this author on:\n\nCarl Watson ;\n\nCarl Watson\n\n11A4P Consulting Ltd, Sandwich, United Kingdom.\n\nSearch for other works by this author on:\n\nJoseph Dal Porto ;\n\nJoseph Dal Porto\n\n12Discovery, Genentech, Inc., South San Francisco, California.\n\nSearch for other works by this author on:\n\nDavid Dejardin ;\n\nDavid Dejardin\n\n13Product Development, Data Science, F. Hoffmann-La Roche Ltd, Basel, Switzerland.\n\nSearch for other works by this author on:\n\nChristopher Del Nagro ;\n\nChristopher Del Nagro\n\n14Research & Early Development Oncology, F. Hoffmann-La Roche Ltd, Zurich, Switzerland.\n\nSearch for other works by this author on:\n\nValeria Nicolini ;\n\nValeria Nicolini\n\n10F. Hoffmann-La Roche Ltd, Research & Early Development Oncology, Basel, Switzerland.\n\nSearch for other works by this author on:\n\nStefan Evers ;\n\nStefan Evers\n\n10F. Hoffmann-La Roche Ltd, Research & Early Development Oncology, Basel, Switzerland.\n\nSearch for other works by this author on:\n\nChristian Klein ;\n\nChristian Klein\n\n14Research & Early Development Oncology, F. Hoffmann-La Roche Ltd, Zurich, Switzerland.\n\nSearch for other works by this author on:\n\nBarbara Leutgeb ;\n\nBarbara Leutgeb\n\n15Product Development Oncology F. Hoffmann-La Roche Ltd, Basel, Switzerland.\n\nSearch for other works by this author on:\n\nPavel Pisa ;\n\nPavel Pisa\n\n14Research & Early Development Oncology, F. Hoffmann-La Roche Ltd, Zurich, Switzerland.\n\nSearch for other works by this author on:\n\nEva Rossmann ;\n\nEva Rossmann\n\n16Product Development, Safety Science, F. Hoffmann-La Roche Ltd, Basel, Switzerland.\n\nSearch for other works by this author on:\n\nJosé Saro ;\n\nJosé Saro\n\n14Research & Early Development Oncology, F. Hoffmann-La Roche Ltd, Zurich, Switzerland.\n\nSearch for other works by this author on:\n\nPablo Umana ;\n\nPablo Umana\n\n14Research & Early Development Oncology, F. Hoffmann-La Roche Ltd, Zurich, Switzerland.\n\nSearch for other works by this author on:\n\nJehad Charo ;\n\nJehad Charo\n\n14Research & Early Development Oncology, F. Hoffmann-La Roche Ltd, Zurich, Switzerland.\n\nSearch for other works by this author on:\n\nVolker Teichgräber ;\n\nVolker Teichgräber\n\n10F. Hoffmann-La Roche Ltd, Research & Early Development Oncology, Basel, Switzerland.\n\nSearch for other works by this author on:\n\nNeeltje Steeghs\n\nNeeltje Steeghs\n\n17Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.\n\nSearch for other works by this author on:\n\nReceived:\n\nRevision Received:\n\nAccepted:\n\nOnline ISSN: 1557-3265\n\nPrint ISSN: 1078-0432\n\nFunding Group:\n\nAward Group:\n\nFunder(s):\n\nF. Hoffmann-La Roche Ltd\n\nPrincipal Award Recipient(s):\n\nS.\n\nE.\n\nT.\n\nK.S.\n\nI.\n\nB.\n\nJ.L.\n\nJ.\n\nC.\n\nC.\n\nC.\n\nJ.D.\n\nD.\n\nC.J.\n\nV.G.\n\nS.\n\nC.\n\nB.\n\nP.\n\nE.\n\nJ.\n\nP.\n\nJ.\n\nV.\n\nN.\n\nPeters\n\nANGEVIN\n\nAlonso-Gordoa\n\nRohrberg\n\nMelero\n\nMellado\n\nPerez-Gracia\n\nTabernero\n\nAdessi\n\nBoetsch\n\nWatson\n\nPorto\n\nDejardin\n\nDelNagro\n\nNicolini\n\nEvers\n\nKlein\n\nLeutgeb\n\nPisa\n\nRossmann\n\nSaro\n\nUmana\n\nCharo\n\nTeichgräber\n\nSteeghs\n\n©2024 American Association for Cancer Research\n\n2024\n\nAmerican Association for Cancer Research\n\nClin Cancer Res (2024) 30 (8): 1630–1641."
    }
}